BNTGF:OTC-Brenntag SE (USD)

COMMON STOCK | Specialty Chemicals | OTC

Last Closing Price

USD 87.15

Change

0.00 (0.00)%

Market Cap

USD 13.42B

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Brenntag SE purchases and supplies various industrial and specialty chemicals, and ingredients in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. It provides value-added services, such as just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling, as well as technical and laboratory services for specialty chemicals. The company serves customers in various end-market industries, including nutrition, pharma, personal care, water treatment, and lubricants; and home, industrial, and institutional markets, as well as coatings and constructions, polymers, and rubber material science industries. Brenntag SE was founded in 1874 and is based in Essen, Germany.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-04-14 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SXYAY Sika AG

-0.38 (-1.32%)

USD40.74B 50.97 29.49
SKFOF Sika AG

-5.29 (-1.81%)

USD40.73B 51.73 30.18
GVDBF Givaudan SA

N/A

USD39.22B 49.40 31.32
GVDNY Givaudan SA

-0.02 (-0.02%)

USD38.30B 48.26 31.32
NPCPF Nippon Paint Holdings Co., Ltd

N/A

USD33.49B 61.42 0.29
RDSMY Koninklijke DSM N.V

-0.17 (-0.38%)

USD30.84B 52.07 23.63
KDSKF Koninklijke DSM N.V

-1.98 (-1.10%)

USD30.48B 52.34 23.63
AKZOF Akzo Nobel N.V

N/A

USD21.92B 29.97 17.08
AKZOY Akzo Nobel N.V

-0.73 (-1.86%)

USD21.74B 29.81 17.08
EMSHF EMS-CHEMIE HOLDING AG

N/A

USD20.93B 44.35 36.74

ETFs Containing BNTGF

Symbol Name Weight Mer Price(Change) Market Cap
DJMC:LSE iShares EURO STOXX Mid UC.. 0.00 % 0.40 %

+13.50 (+0.23%)

USD0.42B
C007:F ComStage MDAX UCITS ETF 0.00 % 0.30 %

+0.08 (+0.26%)

USD0.19B
C064:F ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

USD0.01B
E907:F Lyxor 1 MDAX UCITS ETF 0.00 % 0.30 %

+0.30 (+0.17%)

USD0.11B
EDMF:F iShares Edge MSCI EMU Mul.. 0.00 % 0.40 %

N/A

USD6.91M
ELF1:F Deka MDAX UCITS ETF 0.00 % 0.00 %

+0.40 (+0.13%)

USD0.56B
EXS3:F iShares MDAX UCITS ETF (D.. 0.00 % 0.51 %

+0.70 (+0.26%)

USD5,933.92B
EXV7:F iShares STOXX Europe 600 .. 0.00 % 0.46 %

-0.54 (-0.45%)

USD0.13B
F751:F ComStage Alpha Deutschlan.. 0.00 % 0.69 %

N/A

USD0.01B
C007:XETRA Lyxor MDAX (DR) UCITS ETF 0.00 % 0.30 %

+0.05 (+0.15%)

USD0.23B
C064:XETRA ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

USD0.01B
E907:XETRA Lyxor 1 MDAX UCITS ETF 0.00 % 0.30 %

+0.28 (+0.16%)

USD0.20B
ELF1:XETRA Deka MDAX UCITS ETF 0.00 % 0.00 %

+0.40 (+0.13%)

USD0.69B
EXS3:XETRA iShares MDAX UCITS ETF (D.. 0.00 % 0.51 %

+0.10 (+0.04%)

USD5,933.92B
EXV7:XETRA iShares STOXX Europe 600 .. 0.00 % 0.46 %

-0.36 (-0.30%)

USD0.13B
F751:XETRA ComStage Alpha Deutschlan.. 0.00 % 0.69 %

N/A

USD0.01B

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.67% 49% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.67% 48% F 43% F
Trailing 12 Months  
Capital Gain 137.66% 71% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 137.66% 69% D+ 69% D+
Trailing 5 Years  
Capital Gain 50.88% 47% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.88% 47% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 7.45% 51% F 51% F
Dividend Return 2.02% 66% D 49% F
Total Return 9.48% 47% F 51% F
Risk Return Profile  
Volatility (Standard Deviation) 28.31% 62% D- 64% D
Risk Adjusted Return 33.48% 62% D- 64% D
Market Capitalization 13.42B 85% B 91% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 24.26 56% F 35% F
Price/Book Ratio 3.20 48% F 36% F
Price / Cash Flow Ratio 11.01 32% F 17% F
EV/EBITDA 15.09 44% F 26% F
Management Effectiveness  
Return on Equity 13.18% 75% C 81% B-
Return on Invested Capital 10.39% 65% D 74% C
Return on Assets 5.26% 75% C 85% B
Debt to Equity Ratio 41.45% 59% F 40% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.16 33% F 39% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector